Pfizer Reports Positive Topline Phase 3 Results For HYMPAVZI™ In Hemophilia A or B With Inhibitors
Pfizer Inc. (NYSE:PFE) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Pfizer Inc.
Pfizer Inc (PFE)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Diamond Hill Capital Ric Dillon | 17,664,353 | $428,183,917 | -6% | 1.97% |
| 2. | Pzena Investment Management Richard S. Pzena | 6,559,114 | $158,992,924 | -8% | 0.52% |
| 3. | Entropy Technologies Vikram Modi And Arjun Modi | 537,233 | $13,022,528 | +187% | 1.03% |
| 4. | 439,300 | $10,648,632 | -38% | 0.06% | |
| 5. | Hourglass Capital Kenneth A. Moffet | 436,440 | $10,579,306 | +9% | 2.62% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.65 | 19,457 | $499,072.05 | 27,707 | 2025-02-13 | Filing | |
| $28.24 | 1,000 | $28,240.00 | 10,000 | 2024-10-30 | Filing | |
| $26.47 | 3,000 | $79,401.00 | 9,000 | 2023-12-15 | Filing | |
| $38.58 | 1,000 | $38,580.00 | 6,000 | 2023-05-08 | Filing | |
| $38.43 | 1,000 | $38,425.00 | 5,000 | 2023-05-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.93 | 2,500 | $64,825.00 | 11,850 | 2025-03-04 | Filing | |
| $28.66 | 5,154 | $147,713.64 | 8,582 | 2024-08-13 | Filing | |
| $40.02 | 9,912 | $396,678.24 | 9,003 | 2023-03-15 | Filing | |
| $53.96 | 4,218 | $227,603.28 | 10,846 | 2022-06-07 | Filing | |
| $50.50 | 4,000 | $202,000.00 | 15,064 | 2022-05-16 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 533,363,457 | $12,928,730,197 | 0.21% | |
| 2. | 127,471,481 | $3,080,552,327 | 0.22% | |
| 3. | 75,474,322 | $1,829,497,564 | 0.58% | |
| 4. | 35,967,825 | $871,860,088 | 0.16% | |
| 5. | 15,601,116 | $378,171,052 | 0.24% |
News See All
11 Best GLP-1 and Weight Loss Stocks to Invest in
GLP-1 medicines are a type of prescription that mimics a natural hormone that regulates blood sugar and appetite.
Pfizer (PFE) Releases Financial Results for Q2 2025
Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued Long Term Stocks to Buy According to Hedge Funds.
11 Most Undervalued Long Term Stocks to Buy According to Hedge Funds
BlackRock sees risk assets in a tug-of-war between strong US corporate earnings, driven by the AI theme, and tariffs that impact growth while increasing inflation.
Pfizer Inc. (NYSE:PFE) Q2 2025 Earnings Call Transcript
Operator: Good day, everyone, and welcome to Pfizer's Second Quarter 2025 Earnings Conference Call. Today's call is being recorded.
15 Stocks in Jim Cramer’s Game Plan for This Week
On Friday’s episode of Mad Money, host Jim Cramer shared his thoughts on another intense week during earnings season as he turned his attention to several known companies that would be reporting their...
Pfizer Inc. (NYSE:PFE) Announces Q3 2025 Dividend
Pfizer Inc. (NYSE:PFE) is one of the top cheap pharmaceutical stocks to buy now. On June 25, Pfizer Inc.
11 Cheap Pharmaceutical Stocks to Buy Now
The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the steps they should take to decrease the prices of US prescription drugs to “most...
Bank of America Securities Maintains a Hold on Pfizer (PFE)
Pfizer Inc. (NYSE:PFE) is one of the most undervalued blue chip stocks to buy according to hedge funds. Analyst Tim Anderson from Bank of America Securities maintained a Hold rating on Pfizer Inc.
Pfizer’s (PFE) Breakthrough Medicines Power its Dividend Stability
The American multinational biotech firm developed a form of santonin used to treat intestinal worms, which gained rapid popularity thanks to its effectiveness.